Decrease in high on-treatment platelet reactivity (HPR) prevalence on switching from clopidogrel to prasugrel: insights from the switching anti-platelet (SWAP) study

The prevalence of high platelet reactivity (HPR) in patients who have switched from clopidogrel to prasugrel during maintenance phase after an acute coronary syndrome (ACS) event is unknown. Therefore, the effect of switching from clopidogrel to prasugrel on the prevalence of HPR was evaluated. This...

Full description

Saved in:
Bibliographic Details
Published inThrombosis and haemostasis Vol. 109; no. 2; p. 347
Main Authors Saucedo, Jorge F, Angiolillo, Dominick J, DeRaad, Roger, Frelinger, 3rd, Andrew L, Gurbel, Paul A, Costigan, Timothy M, Jakubowski, Joseph A, Ojeh, Clement K, Duvvuru, Suman, Effron, Mark B
Format Journal Article
LanguageEnglish
Published Germany 01.02.2013
Subjects
Online AccessGet more information

Cover

Loading…